Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0038

View: 6432 Download: 195 Web of Science: 43 Crossref: 48

The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care

Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee

Clin Mol Hepatol. 2011;17(3):189-198. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.189

View: 7090 Download: 71 Crossref: 5

3

Clinical features and prognosis of primary biliary cirrhosis in Korea

Kyung-Ah Kim, M.D. Sook-Hyang Jeong, M.D. Jung Il Lee, M.D. Jong Eun Yeon, M.D. Heon Ju Lee, M.D. So Young Kwon, M.D. U Im Chang, M.D. Hyun Ju Min, M.D.

Clin Mol Hepatol. 2010;16(2):139-146. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.139

View: 5547 Download: 82 Crossref: 10

A Comparison of Patients With Hepatocellular Carcinoma Between A Short - term (Less Than 6 months) Survival Group and A Long - term (Over 24 Months) Survival Group After Treatment with Transcatheter Arterial Chemoembolization

In Koo Kang,Sung Woo Kim,Sung Hee Hahn,Seung Chul Cho,Chang Woo Cham,Dong Hoo Lee

Clin Mol Hepatol. 2002;8(2):189-200. Published online January 1, 2000

View: 2420 Download: 25

Prognostic Factors Affecting Survival Rate in Patients with Hepatocellular Carcinoma Treated by Transcatheter Chemoembolization

Sung Woo Kim,Soong hwan Lee,Byung Joo Roh,Jong Cheol Kim,Sung Soo Park,Dong Hoo Lee

Clin Mol Hepatol. 2000;6(3):311-320. Published online January 1, 2000

View: 2472 Download: 18

1 |

Viewed By 5143	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5004	MAFLD: How is it different from NAFLD?
Viewed By 4913	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3638	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3581	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search